Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-23-Speech-1-106"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20070423.17.1-106"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
Mr President, despite the tremendous efforts made by Mr Mikolášik, the rapporteur, there may be significant weaknesses in our position on advanced therapies. If the ethical amendments package is not supported, adequate guarantees will not be provided for countries that do not wish to destroy human life for therapeutic purposes. Guarantees for human dignity may also be lacking. Human dignity is currently under threat from the commercialisation of the human body, interference with the individual’s genetic heritage and the possibility of creating animal-human hybrids.
Europe is right to set human rights standards for the world, even though this sometimes seems a hopeless task. The question arises as to why we adopt such a passive stance with regard to biotechnology and advanced therapies? We may be forced to give in twice. Without a clear ban on the commercialisation of the human body we risk being forced to give in to the market, which will handle trade in cells. Without a clear ban on interfering with an individual’s genetic heritage we risk being forced to give in to a cruel, eugenic and inhuman philosophy. Such a philosophy always gives precedence to the quality of life over its inalienable value and dignity. We should be ashamed that Asia is now setting standards for the European Union in this area. The legislation in question cannot be endorsed without the ethical amendments package."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples